Old Web
English
Sign In
Acemap
>
authorDetail
>
Er Plummer
Er Plummer
Medicine
Cancer research
Oncology
Pharmacokinetics
Internal medicine
5
Papers
70
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Targeting DNA damage repair beyond PARP - further drugs or targets in development
2011
Er Plummer
Show All
Source
Cite
Save
Citations (0)
Poly(ADP-ribose) polymerase-1 (PARP-1) genomics in relation to activity in healthy volunteers and cancer patients
2008
Tomasz Zaremba
Michael Cole
Sally A. Coulthard
Er Plummer
NJ Curtin
Show All
Source
Cite
Save
Citations (3)
A phase Ib study to assess the safety of lexatumumab, a human monoclonal antibody that activates TRAIL-R2, in combination with gemcitabine, pemetrexed, doxorubicin or FOLFIRI
2007
Journal of Clinical Oncology
Branimir I. Sikic
Heather A. Wakelee
M. von Mehren
Nancy L. Lewis
Ah Calvert
Er Plummer
N. L. Fox
T Howard
Suzanne F. Jones
H. A. Burris
Show All
Source
Cite
Save
Citations (46)
Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors.
2006
Journal of Clinical Oncology
Suzanne F. Jones
Er Plummer
Ha. Burris
Albiruni Ryan Abdul Razak
Aa Meluch
Cj Bowen
Dh Williams
Jeffrey P. Hodge
Mohammed M. Dar
Ah Calvert
Show All
Source
Cite
Save
Citations (12)
Phase I and pharmacokinetic study of HGS-ETR2, a fully human agonistic monoclonal antibody to TRAIL-R2, in patients with advanced solid malignancies
2005
Clinical Cancer Research
Gerhardt Attard
Er Plummer
de Bono Js
C. Bale
P Fong
Mary Barrett
N. L. Fox
T Howard
S Ullrich
Ah Calvert
Show All
Source
Cite
Save
Citations (9)
1